The invention generally relates to upconversion nanoparticles and their use as biological sensors. More particularly, the invention provides triplet-triplet annihilation upconversion nanoparticles as background free self-standing biological sensors, and devices and methods thereof.
Triplet-triplet annihilation upconversion nanoparticle (TTA-UCNP) has been emerging as the next generation of photon upconversion materials. These nanoparticles hold great promise in a wide variety of important areas, such as bioimaging, therapy, photoredox catalysis and solar energy harvesting, because of their unique properties such as high upconversion quantum yield, the need for low excitation power long wavelength light (<200 mW/cm2) and potentially tunable excitation/emission wavelength. In particular, optical triplet-triplet annihilation upconversion (TTA-UC) converts low-energy long wavelength photon to high-energy shorter wavelength one. During the process of TTA-UC, low energy photons are first absorbed by a photosensitizer (Sen), which then reach its single excited state (1Sen*). Subsequently, the intersystem crossing (ISC) process occurs. The energy of the photosensitizers transited to their triplet excited state (3Sen*). Due to the long-lived lifetime of triplet excited state, the energy of 3Sen* can transfer to annihilator (An) by triplet-triplet energy transfer process (TTET). Finally, two triplet excited state annihilators (3An*) undergo a TTA process to generate one high-energy singlet excited state annihilator (1An*), and subsequent short-wavelength light emissions. (Singh-Rachford, et al. 2010 Coord. Chem. Rev. 254, 2560-2573; Zhou, et al. 2015 Chem. Rev. 115, 395-465; Zhao, et al. 2011 RSC Adv. 1, 937-950; Filatov, et al. 2016 Chem. Soc. Rev. 45, 4668-4689; Zhao, et al. 2015 Chem. Soc. Rev. 44, 8904-8939; Zhao, et al. 2013 Chem. Soc. Rev. 42, 5323-5351; Zhu, et al. 2017 Chem. Soc. Rev. 46, 1025-1039; Peng, et al. 2015 Chem. Rev. 115, 7502-7542; Liu, et al. 2012 J. Am. Chem. Soc. 134, 5390-5397; Kwon, et al. 2016 ACS Nano. 10, 1512-1521; Huang, et al. 2017 Angew. Chem. Int. Ed. 56, 14400-14404; Ravetz, et al. 2019 Nature. 565, 343-346; Schulze, et al. 2015 Energy Environ. Sci. 8, 103-125.)
To date, a few TTA-UC photosensitizers and annihilators pairs with solid upconversion quantum yields have been reported in deaerated organic solvents. Unfortunately, oxygen molecules diffused in water can rapidly quench 3Sen* and 3An*. In particular, 3Sen* can rapidly sensitize oxygen molecules to generate singlet oxygen (1O2), thereby inhibiting the TTET process from 3Sen* to 3An*, leading to the failure of TTA-UC (
This oxygen-induced quenching problem is an especially strong obstacle in regard to biological applications that must happen in aqueous solutions under an ambient atmosphere. In order to address this key problem, several methods have been attempted in recent years. For example, TTA-UC dyes were encapsulated in mesoporous silica to slow down oxygen diffusion and the concomitant oxygen quenching. However, the existing silica TTA-UCNP cannot block the oxygen quenching completely and thus has suboptimal upconversion performance. In addition, the size of the nanoparticles is very large, typically over 200 nm. Liposomes were also used to encapsulate TTA-UC dyes in order to construct water-dispersible nanoparticles. Similarly, this method was also unable to effectively resolve the oxygen issue in aqueous solution. Recently, to reduce the oxygen-induced TTA-UC quenching, soybean oil has been explored to form TTA-UC oil droplets. Yet, because of the quick oil/water phase separation, the resultant TTA-UC oil droplet appears to have difficulty staying in aqueous solution. In addition, these TTA-UC oil droplets are also large, typically over 100 nm. (Kwon, et al. 2016 ACS Nano. 10, 1512-1521; Huang, et al. 2019 Biomaterials. 201, 77-86; Huang, et al. 2018 Small Methods. 2, 1700370; Askes, et al. 2018 Nat. Rev. Chem. 2, 437-452; Kwon, et al. 2015 ACS Appl. Mater. Interfaces. 7, 318-325; Askes, et al. 2014 Angew. Chem. Int. Ed. 53, 1029-1033; Baluschev, et al. 2016 Mater. Horiz. 3, 478-486; Kouno, et al. 2016 Chem. Sci. 7, 5224-5229; Liu, et al. 2013 J. Am. Chem. Soc. 135, 5029-5037; Tian, et al. 2017 Biomaterials. 112,10-19; Xu, et al. 2018 Nat. Commun. 9, 2698.)
Therefore, a simple strategy to overcome oxygen-quenching trouble for stable water-dispersible and small-size TTA-UCNP under an ambient atmosphere is both urgently needed.
The invention provides novel and simple enzymatic strategy to overcome oxygen-induced triplet-triplet annihilation upconversion quenching. The disclosed invention addresses the long-felt challenges in aqueous TTA-UC due to its sensitivity to oxygen, which has hindered TTA-UC's biological applications under ambient atmosphere. This novel strategy stems from glucose oxidase catalyzed glucose oxidation reaction, which enables rapid oxygen depletion to turn on upconversion in the aqueous solution. Furthermore, self-standing upconversion biological sensors of such nanoparticles are developed to detect glucose and measure the activity of enzymes related to glucose metabolism in a highly specific, sensitive, and background-free manner. The disclosed invention not only overcomes the key roadblock for applications of triplet-triplet annihilation upconversion nanoparticles in aqueous solutions, it also enables the development of triplet-triplet annihilation upconversion nanoparticles as background free self-standing biological sensors.
In one aspect, the invention generally relates to an upconversion nanoparticle comprising an organic photosensitizer and an organic annihilator pair encapsulated in a polymeric material, wherein upon excitation the organic photosensitizer-annihilator pair is capable of undergoing annihilation upconversion to generate emission having a shorter wavelength than that of the excitation.
In another aspect, the invention generally relates to an aqueous composition comprising a plurality of the upconversion nanoparticle disclosed herein.
In yet another aspect, the invention generally relates to a sensor device that comprises upconversion nanoparticles or an aqueous composition disclosed herein.
In yet another aspect, the invention generally relates to a method for detecting glucose. The method comprises: providing an aqueous composition comprising upconversion nanoparticles disclosed herein and glucose oxidase; measuring a rate of triplet-triplet annihilation upconversion; adding a test sample to the aqueous composition; measuring the rate of triplet-triplet annihilation upconversion again; and analyzing the presence and/or concentration of glucose based on measurements with and without the test sample.
In yet another aspect, the invention generally relates to a method for measuring activity of an enzyme related to glucose metabolism. The method comprises: providing an aqueous composition comprising upconversion nanoparticles disclosed herein and glucose; measuring a rate of triplet-triplet annihilation upconversion; adding to the aqueous composition a test sample;
measuring the rate of triplet-triplet annihilation upconversion again; and analyzing enzymatic activity based on measurements with and without the test sample.
The invention is based in part on the discovery of novel and straightforward strategy to overcome the oxygen quenching problem to turn on the upconversion emissions of TTA-UCNP in the aqueous solution. The disclosed approach is based on the simple glucose oxidase (GOX) catalytic reaction, which directly exhaust and deplete the oxygen in the aqueous solution. Moreover, it was demonstrated that this method can be utilized in highly selective glucose sensors and to detect enzymes linked to glucose metabolism. It is believed to be the first demonstration of the long-thought after TTA-UCNP based solution as biological sensors. The disclosed invention should pave the way for using TTA-UCNP in a wide variety of photonic and biophotonic applications that are currently off limit due to the oxygen quenching problem.
Organic TTA-UCNPs based sensors are expected not only to inherit these general merits from inorganic lanthanide UCNPs (e.g., minimized autofluorescence background interference, reduced light scattering and photodamage), but also to have certain distinctive advantages over their inorganic counterparts in regard to biological sensing applications.
The emission of lanthanide UCNPs comes from a number of rare earth ions buried and shielded inside nanoparticles, which cannot respond and react directly to analytes in aqueous solution. In order to be used as biosensors, such inorganic UCNPs typically have to be conjugated with other fluorophore containing molecules (e.g., cyanine dye, rhodamine dye and ruthenium complexes) or by growing materials whose absorption overlaps with upconversion emissions. These inorganic UCNPs sensors rely on an inefficient luminescence resonance energy transfer (LRET) mechanism or on emission-reabsorption process. The readouts of such indirect sensors are often difficult to control due to variations regarding the amount and aggregation of conjugated dyes and the resultant materials. Since the ratios and intensities of these upconversion peaks and overall upconversion colors are heavily dependent on the power density of the excitation light and dopant amounts, the accuracy, sensitivity and robustness of such sensors can often be compromised by the slight variation in these experimental factors. (Wu, et al. 2015 Bioconjug. Chem. 26, 166-175; Punjabi, et al. 2014 ACS Nano. 8, 10621-10630; Liu, et al. 2013 J. Am. Chem. Soc. 135, 9869-9876; Wang, et al. 2017 J. Am. Chem. Soc. 139, 12354-12357; Liu, et al. 2014 J. Am. Chem. Soc. 136, 9701-9709; Deng, et al. 2011 J. Am. Chem. Soc. 133, 20168-20171; Peng, et al. 2017 Angew. Chem. Int. Ed. 56, 4165-4169; Tu, et al. 2014 Coord. Chem. Rev. 273, 13-29; Wen, et al. 2018 Nat. Commun. 9, 2415.)
In contrast, the emission of organic TTA-UCNP is based on the triplet excited states of photosensitizers and annihilators. Thus, similar to organic fluorescence molecules, there is typically one emission peak and no color mixing problem in organic TTA-UC. Unlike the inorganic UCNPs, organic TTA-UCNP can potentially be used as self-standing biosensors to detect analytes that can regulate and affect the triplet properties without any further nanoparticle modifications. In addition, compared to the weak absorption of lanthanides ions in inorganic UCNPs, TTA-UCNP utilizes intense long-wavelength absorbing organic photosensitizers, which lead to a much higher level of brightness and can be triggered with low power LED light.
Glucose oxidase (GOX)-catalyzed glucose oxidation reactions can consume oxygen (
The invention disclosed herein is a simple and straightforward GOX-catalytic method that can quickly deplete oxygen and thus amplify the upconversion intensity of sub-50 nm TTA-UCNP in aqueous solution. Additionally, self-standing “turn-on” upconversion biological sensors are developed based on such enzymatic TTA-UC enhancement strategy. It has been demonstrated that TTA-UCNP can detect glucose and measure the activity of enzymes related to glucose metabolism in a highly specific, sensitive and background-free manner. Thus, this disclosure not only provides a straightforward method for overcoming a key roadblock in using small-size TTA-UCNP for photonic and biophotonic applications in aqueous solutions, but also provides proof-of-concept for use of TTA-UCNP as background free self-standing biological sensors.
In one aspect, the invention generally relates to an upconversion nanoparticle comprising an organic photosensitizer and an organic annihilator pair encapsulated in a polymeric material, wherein upon excitation the organic photosensitizer-annihilator pair is capable of undergoing triplet-triplet annihilation upconversion to generate emission having a shorter wavelength than that of the excitation.
In certain embodiments, the organic photosensitizer is selected from the group consisting of: iridium complexes, metal-porphyrin complexes, metal-benzoporphyrin complexes, boron-dipyrromethene or derivatives thereof.
In certain embodiments, the organic photosensitizer is an iridium complex selected from:
wherein
R is selected from the group consisting of: hydrogen, fluoro, trifluoromethyl, tert-butyl, alkyl, azide, polyethylene glycol (PEG), amine, carboxylic acid, sulfonate and hydroxyl.
Exemplary iridium complexes include:
wherein n is an integer from 1 to 7.
In certain embodiments, the organic photosensitizer is a metal-porphyrin complex selected from:
wherein
Exemplary metal-porphyrin complexes include:
wherein n is an integer from 1 to 7.
In certain embodiments, the organic photosensitizer is a metal-benzoporphyrin complex selected from:
wherein
R is selected from the group consisting of: hydrogen, bromo, iodio, fluro, 1-naphthyl, 1-naphthalenyl, 1-naphthyloro, aldehyde, phenyl, styryl, phenylethynyl, alkynyl, vinyl, 2-naphthyl, 2-naphthalenyl, 2-naphthyl, 2-fluorenyl, 2-fluorenyl alkynyl, carbazolyl, carbazolyl alkynyl, alkynyl, hydroxy, amino, alkynyl, alkyl, alkenyl, azide, PEG, amine, carboxylic acid, sulfonate and hydroxyl.
Exemplary metal-benzoporphyrin complexes include:
wherein n is 1, 2, 3, 4, 5, 6 or 7.
In certain embodiments, the organic photosensitizer is a boron-dipyrromethene derivative selected from:
wherein
Targeted molecules include biological active or functional small molecular drugs, proteins, peptides, amino acids, and nucleic acid molecules (e.g., DNAs).
Exemplary boron-dipyrromethene derivatives include:
wherein n is 1, 2, 3, 4, 5, 6 or 7.
In certain embodiments, the organic photosensitizer is an iridium complex.
In certain embodiments, the organic photosensitizer is a metal-porphyrin complex.
In certain embodiments, the organic photosensitizer is a metal-benzoporphyrin complex.
In certain embodiments, the organic photosensitizer is a boron-dipyrromethene derivative.
In certain embodiments, the organic annihilator is selected from the group consisting of: coumarin or derivatives thereof, anthracene derivatives, perylene or derivatives thereof.
In certain embodiments, the organic annihilator is a coumarin derivative selected from:
wherein
R1 can be the following functional groups: hydrogen, bromo, iodio, and aldehyde, alkynyl and alkenyl;
R2 can be the following functional groups: hydrogen, bromo, iodio, hydroxy, amino and nitro;
R3 can be the following functional groups: alkynyl, alkyl, alkenyl, azide, PEG, amine, carboxylic acid, sulfonate and hydroxyl; and
R4 can be the following functional groups: alkynyl, alkyl, alkenyl, azide, PEG, amine, carboxylic acid, sulfonate and hydroxyl.
Exemplary coumarin derivatives include:
wherein n is 1, 2, 3, 4, 5, 6 or 7.
In certain embodiments, the organic annihilator is an anthracene derivative selected from:
wherein
Exemplary anthracene derivatives include:
wherein n is 1, 2, 3, 4, 5, 6 or 7.
In certain embodiments, the organic annihilator is a perylene derivative selected from:
wherein
Targeted molecules include biological active or functional small molecular drugs, proteins, peptides, amino acids, and nucleic acid molecules (e.g., DNAs).
Exemplary perylene derivatives include:
wherein n is 1, 2, 3, 4, 5, 6 or 7.
In certain embodiments, the organic annihilator is perylene or a derivative thereof
In certain embodiments, the organic photosensitizer is PdTPBP and the organic annihilator is perylene.
In certain embodiments, the polymeric material is an amphiphilic polymer selected from dodecane substituted PAA and octadecane substituted PAA.
In certain embodiments, the polymeric material is PAA-OA.
In certain embodiments, the upconversion nanoparticle has a particle size in the range of about 50 nm to about 200 nm (e.g., about 50 nm to about 100 nm, about 100 nm to about 150 nm, or about 150 nm to about 200 nm).
In certain embodiments, the upconversion nanoparticle has a particle size less than about 50 nm.
In certain embodiments, the upconversion nanoparticle is water dispersible.
In another aspect, the invention generally relates to an aqueous composition comprising a plurality of the upconversion nanoparticle disclosed herein.
In certain embodiments, the aqueous composition further comprises glucose (e.g., D-glucose).
In certain embodiments, the aqueous composition further comprises glucose oxidase.
In certain embodiments, the aqueous composition comprises glucose and glucose oxidase.
In yet another aspect, the invention generally relates to a sensor device that comprises upconversion nanoparticles or an aqueous composition disclosed herein.
In yet another aspect, the invention generally relates to a method for detecting glucose. The method comprises: providing an aqueous composition comprising upconversion nanoparticles disclosed herein and glucose oxidase; measuring a rate of triplet-triplet annihilation upconversion; adding a test sample to the aqueous composition; measuring the rate of triplet-triplet annihilation upconversion again; and analyzing the presence and/or concentration of glucose based on measurements with and without the test sample.
In yet another aspect, the invention generally relates to a method for measuring activity of an enzyme related to glucose metabolism. The method comprises: providing an aqueous composition comprising upconversion nanoparticles disclosed herein and glucose; measuring a rate of triplet-triplet annihilation upconversion; adding to the aqueous composition a test sample; measuring the rate of triplet-triplet annihilation upconversion again; and analyzing enzymatic activity based on measurements with and without the test sample.
In certain embodiments, measuring a rate of triplet-triplet annihilation upconversion comprises directing an excitation light beam corresponding to the singlet excitation state of the organic photosensitizer at the aqueous composition and measuring an emission therefrom at a wavelength longer than the excitation light beam.
In certain embodiments, analyzing the presence and/or concentration of glucose comprises measuring concertation of glucose half response time of triplet-triplet annihilation upconversion.
In certain embodiments, the organic photosensitizer is PdTPBP, the organic annihilator is perylene, and the polymeric material is PAA-OA.
In certain embodiments, the excitation light beam has a wavelength at about 650 nm and the emission has a wavelength at about 480 nm.
In certain embodiments, the enzyme related to glucose metabolism is selected from invertase (β-fructofuranosidase), glucose dehydrogenase and gluconate kinase.
In certain embodiments, the enzyme related to glucose metabolism is invertase (β-fructofuranosidase).
The following examples are meant to be illustrative of the practice of the invention and not limiting in any way.
As a proof-of-principle, palladium (II) meso-tetraphenyl-tetrabenzoporphyrin (PdTPBP) and perylene were used as the sensitizer and annihilator, as they are one of the most investigated and effective long wavelength activating TTA-UC dye pairs used in organic solvent. As the annihilator, perylene has (
To obtain a water-dispersible TTA-UCNP, this TTA dye pair (PdTPBP/perylene) was encapsulated (
Next, the photophysical properties of this TTA-UCNP in phosphate-buffered saline (PBS) were investigated. The schematic diagram of instrument setup was presented on
Since the phosphorescence of PdTPBP is sensitive to oxygen (
Moreover, the influence of GOX concentration on the TTA-UC was studied by detecting the kinetic rates of TTA-UC emission intensity for these TTA-UCNP under 650 nm illumination. This was done with different concentrations of GOX and the fixed concentration of glucose (5 mg mL-1). A higher concentration of GOX was found to lead to a decreased upconversion half response time (t½). For example, t½ was shortened from 142 seconds to 20 seconds when the GOX concentration increased from 1.3 μg mL-1 to 32.5 μg mL-1 (
Next, the feasibility of using this TTA-UC enhancement strategy to sense glucose in aqueous solution was explored. D-glucose has played key roles in a wide variety of biological processes in living organisms. An abnormal level of glucose in body fluid has been linked to several life-threatening diseases, such as diabetes, nephritis, as well as liver damage. Therefore, glucose sensing has considerable importance in the biomedical field. (Zimmet, et al. 2001 Nature 414, 782-787; Vallon, et al. 2020 Nat. Rev. Nephrol. 16, 317-336; Targher, et al. 2018 Nat. Rev. Endocrino. l. 14, 99-114; Shokrekhodaei, et al. 2020 Sensors 20, 1251.)
Prior to the present disclosure, the fluorescence glucose sensors were developed according to the capability of organic boronic acids to act as molecular receptors for saccharides, especially glucose. Yet, the affinity of boronic acid towards glucose are not optimal and its glucose selectivity is not specific. Meanwhile, in such a strategy, the conjugated reporter chromophores, such as anthracene, phenanthrene and naphthalene, are typically involved in short wavelength light excitation and emission (ultraviolet or blue light), the latter of which suffers from autofluorescence background from the biological fluids. Additionally, fluorescent probes or nanoparticles (gold or silver) were also used to indirectly estimate the amount of glucose by responding to H2O2 or protons (the products of the GOX catalytic glucose oxidation reactions). However, almost all these reported optical glucose sensors are based on changes in “downconverting” fluorescence or absorbance. Therefore, background interference remains and greatly reduces the specificity and sensitivity of glucose. Since upconversion materials have opposite optical profiles compared to conventional fluorescence chromophores, it was envisioned that unique GOX mediate TTA-UC enhancement can be used as a background-free glucose sensor. (Sun, et al. 2015 Chem. Rev. 115, 8001-8037; Steiner, et al. 2011 Chem. Soc. Rev. 40, 4805-4839; Guan, et al. 2013 Chem. Soc. Rev. 42, 8106-8121; Sedlmeier, et al. 2015 Chem. Soc. Rev. 44, 1526-1560; Chen, et al. 2014 Chem. Rev. 114, 5161-5214; Chen, et al. 2016 Chem. Rev. 116, 2826-2885.)
As has been shown in above-mentioned experimental results (
a Rosenzweig, et al. 1996 Anal. Chem. 68, 1408-1413.
b Bukowski, et al. 2007 Electron. Lett. 43, 202-204.
c Schäferling, et al. 2004 J. Fluoresc. 5, 561-568.
d James, et al. 1995 J. Am. Chem. Soc. 117, 8982-8987.
Notably in previous studies, it was necessary to embed the chromophores, such as Ru, Pd, Pt complexes and GOX, in a polymer or hydrogel in order to make the device measure the glucose content. (Steiner, et al. 2011 Chem. Soc. Rev. 40, 4805-4839.) In contrast, TTA-UCNP can be directly used to measure the glucose in aqueous solution without the requirement of a complicated device preparation process. For the purpose of direct comparison, as an example, the system disclosed herein was compared head-to-head with a well-established Ru(bpy)3 in a nanoparticle formation to measure the glucose in the aqueous solution. (Moreno-Bondi, et al. 1990 Anal. Cham. 62, 2377-2380; Li, et al. 1995 Anal. Chem. 67, 3746-3752.)
In this controlled study, Ru NPs were constructed like the protocol with TTA-UCNP. As shown in
Next, TTA-UCNP was studied in conjugation with GOX as sensors in order to measure the activity of enzymes related to glucose metabolism. As a proof-of-principle, the activity of the invertase (β-fructofuranosidase) was studied using the TTA-UCNP sensor. The invertase is an important enzyme that catalyzes hydrolysis of sucrose to produce D-glucose and D-fructose. These enzymes broadly exist in plants, microorganisms, and humans. In particular, the activity of such an enzyme must be routinely measured in the many areas of biology, and bioengineering. To date, invertase activity is determined by a couple of enzyme assays in which invertase cleaves sucrose to glucose and fructose, resulting in a colorimetric product, proportional to the invertase activity present. However, these existing methods are based on additional colored indicators, such as oxiRed probe (absorbance at 570 nm) to determine invertase activity. Moreover, there are typically biological pigments in the samples, such as chlorophyll, carotenes and phytochromes, which have significant interference when measuring the activity of invertase. (Roitsch, et al. 2004 Trends Plant Sci. 9, 606-613; Lincoln, et al. 2017 J. Basic. Microbiol. 57, 803-813; Kulshrestha, et al. 2013 J. Pharm. Res. 7, 792-797; Dambrouck, et al. 2005 J. Agric. Food. Chem. 53, 8782-8789; Romero-Gómez, et al. 2000 Biotechnol. Lett. 22, 1255-1258; Aguiar, et al. 2014 Mol Biotechnol. 56, 524-534; Shivalingamurthy, et al. 2018 Front Plant Sci. 9, 598; The commercialized products for invertase activity assay kit (sensitive): https://www.abcam.com/invertase-activity-assay-kit-colorimetric-ab197005.html.)
Contrary to these existing methods, the unique TTA-UC properties in the disclosed method is expected to overcome the problematic background interference and to minimize cross-talking with auto-fluorescence from the samples.
As shown in
Perylene, octadecylamine, poly (isobutylene-alt-maleic anhydride) Mw=6000, tetrahydrofuran (THF), N, N-dimethylformamide (DMF), glucose, glucose oxidase and invertase were purchased from Sigma-Aldrich (St. Louis, MO, U.S.). Meso-tetraphenyl-tetrabenzoporphine palladium complex (PdTPBP) was purchased from Fisher Scientific. Ultrapure water was prepared by using a Millipore Simplicity System (Millipore, Bedford, U.S.). All of the above-mentioned chemicals were used as received without further purification.
UV-vis spectra were recorded via an Agilent Cary-5 spectrophotometer. Steady-state fluorescence spectra were measured with a Hitachi F-7000 fluorescence spectrometer. The morphology of the TTA-UC nanoparticle was characterized by using a JEOL JEM-200CX transmission electron microscope (TEM) operated at 80 kv. The sample for TEM measurement was prepared by dropping the solution onto a carbon-coated copper grid after negative staining with 10.0% (w/v) sodium phosphotungstic acid. The particle size and size distribution of the TTA-UCNP in aqueous solution was measured by using dynamic light scattering (DLS) via a Malvern Zetasizer Nano ZS. The original data is re-drawn and analyzed on Origin Pro 8.
Poly (isobutylene-alt-maleic anhydride) (Mw 6000) (1.85 g) and octadecylamine (1.6 g) were dissolved in dry THF (100 mL). They were then left to react for 24 h at 70° C. The solvent was evaporated under reduced pressure to attain the PAA-OA product.
The TTA-UCNP was prepared via self-assembly of the sensitizer (PdTPBP), the annihilator (perylene) with PAA-OA. Briefly, PdTPBP (50 μM), perylene (1 mM) and PAA-OA (75 mg) were dissolved in 5 mL THF, and followed by the addition of 5 mL 50 mM sodium borate buffer (with a pH of 9.16). The mixture solution was stirred in 40° C. for 2 h and the volume of the solution is reduced due to the evaporation of the THF. The reaction mixture was then cooled to room temperature and dialyzed in deionized water for 24 h. After that the nanoparticles were concentrated to 5 mL via an ultracentrifuge tube (cut off Mw=3000). The TTA-UCNP solution was then stored at 4° C. The PdTPBP nanoparticles (PdTPBP NP) was prepared by a similar method. PdTPBP (50 μM) and PAA-OA (75 mg) were used for preparing PdTPBP NP.
A continuous diode-pumped solid-state laser (650 nm) was used as the excitation source for the upconversion measurement. For the upconversion measurements, the mixed solution of PdTPBP and perylene was degassed with Argon for 15 min. The solution was then excited with the laser, and the corrected upconversion spectrum was recorded with a HORIBA spectrofluorometer.
The ΦUC was calculated by an established method. (Singh-Rachford, et al. 2010 Coord. Chem. Rev. 254, 2560-2573; Huang, et al. 2017 Angew. Chem. Int. Ed. 56, 14400-14404.) The methylene blue (MB) in methanol with fluorescence quantum yield (Φ71 =3%) was used as the reference. The upconversion quantum yield was calculated with Equation (1), where ΦUC, Astd, Istd, and ηstd represent the upconversion quantum yield, the absorbance of the reference, the integrated photoluminescence intensity of the reference, and the refractive index of the solvents:
where ΦUC, Astd, Istd, and ƒstd represent the upconversion quantum yield, the absorbance of the reference, the integrated photoluminescence intensity of the reference, and the refractive index of the solvents.
Entrapment efficiency of dyes was measured via a reported protocol. The absorbance of PdTPBP or perylene in dichloromethane (A0) before synthesis of the TTA-UCNP was measured. The dichloromethane was added to extract the PdTPBP and the perylene from the final TTA-UCNP product to attain absorbance (A) for PdTPBP or perylene in the TTA-UCNP. Then the entrapment efficiency of PdTPBP or perylene was calculated according to Equation (2) that has been used similarly in the literature. (Huang, et al. 2016 J. Am. Chem. Soc. 138, 14586-14591.)
A continuous diode-pumped solid-state laser (650 nm) was used as the excitation source for the upconversion. For the upconversion measurements, the TTA-UCNP was irradiated by 650 nm laser under different conditions (in the absence of glucose and GOX, in the presence of glucose and GOX, in the presence of glucose or GOX alone). The upconversion emission spectra of TTA-UCNP were recorded with a HORIBA spectrofluorometer after the upconversion emission intensities of the TTA-UCNP were stabilized. The ΦUC of the TTA-UCNP in PBS buffer was calculated according to above-mentioned equation. The TTA upconversion brightness is then calculated according to Equation (3) that has been used similarly in the literature (Wu, et al. 2012 J. Org. Chem. 77, 5305-5312)
where η is the TTA upconversion brightness; ΦUC is the TTA upconversion quantm yield of TTA-UCNP; ε is the molar extinction absorption coefficient of PdTPBP.
The PdTPBP-to-perylene triplet-triplet energy transfer quantum yield in TTA-UCNP was calculated from the measurements of the PdTPBP phosphorescence in the presence of perylene (I, TTA-UCNP) and in the absence of the perylene (I0, PdTPBP NP), using Equation (4) that has been used in the literature. (Mattiello, et al. 2016 Adv. Funct. Mater. 26, 8447-8454.)
The detection limit of glucose was calculated based on a reported method. (Peng, et al. 2009 Sens. Actuators B Chem. 136, 80-85.) A linear relation exists between the half response time (y, t½) and the concentration of glucose in In-In coordination (
Based on the theory of Martins and Naes, the detection limit can be derived from the signal processing performance, as in Equation (6) described below (Martins, T. Naes, Multivariate Calibration, Wiley & Sons, New York, 1998)
where yi is the average value from the calculation and y is the measured data points.
The background of root-mean-square (rms) rmsnoise is calculated using Equation (7)
Where N is the number of data points (N=3) used for the average value.
Then the detection limit of the glucose is calculated to be 0.06 mg mL-1 using Equation (8).
First, the half response time of TTA-UCNP (1 mg mL-1) in conjunction with GOX (10 μg mL-1) was measured at different concentrations of glucose (0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.7, 1.1, 1.5, 2.0 mg mL-1) to attain the standard curve in deionized water. The results were shown in
The process for the calculation of detection limit of invertase is similar with the above-mentioned calculation of the detection limit of glucose. A linear relation exists between the half response time (y, t½) and the activity of invertase (x, unit) in In-In coordination (
Then using the above-mentioned equations for glucose detection limit, the invertase detection limit is calculated to be 0.01 unit.
Applicant's disclosure is described herein in preferred embodiments with reference to the Figures, in which like numbers represent the same or similar elements. Reference throughout this specification to “one embodiment,” “an embodiment,” or similar language means that a particular feature, structure, or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, appearances of the phrases “in one embodiment,” “in an embodiment,” and similar language throughout this specification may, but do not necessarily, all refer to the same embodiment.
The described features, structures, or characteristics of Applicant's disclosure may be combined in any suitable manner in one or more embodiments. In the description, herein, numerous specific details are recited to provide a thorough understanding of embodiments of the invention. One skilled in the relevant art will recognize, however, that Applicant's composition and/or method may be practiced without one or more of the specific details, or with other methods, components, materials, and so forth. In other instances, well-known structures, materials, or operations are not shown or described in detail to avoid obscuring aspects of the disclosure.
In this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural reference, unless the context clearly dictates otherwise.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present disclosure, the preferred methods and materials are now described. Methods recited herein may be carried out in any order that is logically possible, in addition to a particular order disclosed.
References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made in this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material explicitly set forth herein is only incorporated to the extent that no conflict arises between that incorporated material and the present disclosure material. In the event of a conflict, the conflict is to be resolved in favor of the present disclosure as the preferred disclosure.
The representative examples are intended to help illustrate the invention, and are not intended to, nor should they be construed to, limit the scope of the invention. Indeed, various modifications of the invention and many further embodiments thereof, in addition to those shown and described herein, will become apparent to those skilled in the art from the full contents of this document, including the examples and the references to the scientific and patent literature included herein. The examples contain important additional information, exemplification and guidance that can be adapted to the practice of this invention in its various embodiments and equivalents thereof.
This application claims the benefit of priority to U.S. Provisional Application No. 63/320,063, filed Mar. 15, 2022, the entire content of which is incorporated herein by reference for all purposes.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US23/14749 | 3/7/2023 | WO |
Number | Date | Country | |
---|---|---|---|
63320063 | Mar 2022 | US |